title: Molecular evidence supporting the portal theory: a causative link between visceral adiposity and hepatic insulin resistance.
abstract: The mechanism by which increased central adiposity causes hepatic insulin resistance is unclear. The "portal hypothesis" implicates increased lipolytic activity in the visceral fat and therefore increased delivery of free fatty acids (FFA) to the liver, ultimately leading to liver insulin resistance. To test the portal hypothesis at the transcriptional level, we studied expression of several genes involved in glucose and lipid metabolism in the fat-fed dog model with visceral adiposity vs. controls (n = 6). Tissue samples were obtained from dogs after 12 wk of either moderate fat (42% calories from fat; n = 6) or control diet (35% calories from fat). Northern blot analysis revealed an increase in the ratio of visceral to subcutaneous (v/s ratio) mRNA expression of both lipoprotein lipase (LPL) and peroxisome proliferator-activated receptor-gamma (PPARgamma). In addition, the ratio for sterol regulatory element-binding transcription factor-1 (SREBP-1) tended to be higher in fat-fed dogs, suggesting enhanced lipid accumulation in the visceral fat depot. The v/s ratio of hormone-sensitive lipase (HSL) increased significantly, implicating a higher rate of lipolysis in visceral adipose despite hyperinsulinemia in obese dogs. In fat-fed dogs, liver SREBP-1 expression was increased significantly, with a tendency for increased fatty acid-binding protein (FABP) expression. In addition, glucose-6-phosphatase (G-6-Pase) and phosphoenolpyruvate carboxykinase (PEPCK) increased significantly, consistent with enhanced gluconeogenesis. Liver triglyceride content was elevated 45% in fat-fed animals vs. controls. Moreover, insulin receptor binding was 50% lower in fat-fed dogs. Increased gene expression promoting lipid accumulation and lipolysis in visceral fat, as well as elevated rate-limiting gluconeogenic enzyme expression in the liver, is consistent with the portal theory. Further studies will need to be performed to determine whether FFA are involved directly in this pathway and whether other signals (either humoral and/or neural) may contribute to the development of hepatic insulin resistance observed with visceral obesity.
authors.affiliation: Dept. of Physiology and Biophysics, University of Southern California Keck School of Medicine, 1333 San Pablo Street, MMR 626, Los Angeles, CA 90033, USA.
authors.forename: Morvarid
authors.initials: M
authors.lastname: Kabir
authors.forename: Karyn J
authors.initials: KJ
authors.lastname: Catalano
authors.forename: Suchitra
authors.initials: S
authors.lastname: Ananthnarayan
authors.forename: Stella P
authors.initials: SP
authors.lastname: Kim
authors.forename: Gregg W
authors.initials: GW
authors.lastname: Van Citters
authors.forename: Melvin K
authors.initials: MK
authors.lastname: Dea
authors.forename: Richard N
authors.initials: RN
authors.lastname: Bergman
mesh_terms: D000273:Adipose Tissue / Q000378:metabolism*; D000818:Animals; D001824:Body Constitution / Q000502:physiology; D015984:Causality; D004041:Dietary Fats / Q000378:metabolism; D004285:Dogs; D005786:Gene Expression Regulation / Q000502:physiology; D005947:Glucose / Q000378:metabolism*; D007333:Insulin Resistance / Q000502:physiology*; D050356:Lipid Metabolism; D008099:Liver / Q000378:metabolism*; D008297:Male; D008954:Models, Biological; D009928:Organ Specificity; D013223:Statistics as Topic; D014781:Viscera / Q000378:metabolism*
chemical_list: D004041:Dietary Fats; D005947:Glucose